Media Resources & Contact
In this story
NSW Health Pathology’s Cancer Genomics Service offers genetic testing to provide accurate cancer diagnosis’ and help treating clinicians select the most effective treatment for their patients.
Genomics can also predict a person’s risk of developing a particular set of cancers, including inherited gene abnormalities or genetic predispositions.
For over 25 years, the dedicated scientists and technicians at NSW Health Pathology’s Division of Molecular Medicine, led by Laureate Professor Rodney J. Scott, have been working to accurately diagnose genetic predispositions to breast cancer.
“Our Newcastle Division of Molecular Medicine is at the forefront of genetic medicine and research and is one of the largest dedicated centres for screening and diagnosis of breast cancer in Australia. We have provided genetic testing for over 30,000 patients in NSW,” said Professor Scott.
“By equipping patients and their treating doctors with accurate testing results and knowledge about their genetic predisposition to breast cancer, we help to ensure that potentially lifesaving monitoring, early detection strategies and treatment therapies can be put in place.”
Knowledge about the genetic basis of breast cancer risk is constantly evolving and breast cancer treatments are continually improving, especially for those with a genetic predisposition to disease.
“Our internationally-recognised, highly-skilled genetic pathologists, scientists and technicians are constantly updating their approach and developing faster, more comprehensive tests to remain at the forefront of cancer predisposition testing and diagnosis,” said Martin Canova, NSWHP Director Strategy & Transformation.
“We continue to use genomics in new ways to improve patient care and the health of our communities.”